238
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Chitosan-based systems for intranasal immunization against foot-and-mouth disease

, , , , , , & show all
Pages 181-188 | Received 15 Oct 2012, Accepted 13 Dec 2012, Published online: 04 Feb 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Amrish Kumar, Aditya Nath Pandey & Sunil Kumar Jain. (2016) Nasal-nanotechnology: revolution for efficient therapeutics delivery. Drug Delivery 23:3, pages 671-683.
Read now

Articles from other publishers (11)

Selin Parmaksız, Mert Pekcan, Aykut Özkul, Ece Türkmen, Vanessa Rivero-Arredondo, Luis Ontiveros-Padilla, Neil Forbes, Yvonne Perrie, Constantino López-Macías & Sevda Şenel. (2023) In vivo evaluation of new adjuvant systems based on combination of Salmonella Typhi porins with particulate systems: Liposomes versus polymeric particles. International Journal of Pharmaceutics 648, pages 123568.
Crossref
Selin Parmaksız, Aytül Gül, Sedef Erkunt Alak, Muhammet Karakavuk, Hüseyin Can, Ceren Gül, Tuğba Karakavuk, Constantino López-Macías, Nuhan Puralı, Mert Döşkaya & Sevda Şenel. (2022) Development of multistage recombinant protein vaccine formulations against toxoplasmosis using a new chitosan and porin based adjuvant system. International Journal of Pharmaceutics 626, pages 122199.
Crossref
Fudong Zhang, Zhongwang Zhang, Xian Li, Jiahao Li, Jianliang Lv, Zhongyuan Ma & Li Pan. (2021) Immune Responses to Orally Administered Recombinant Lactococcus lactis Expressing Multi-Epitope Proteins Targeting M Cells of Foot-and-Mouth Disease Virus. Viruses 13:10, pages 2036.
Crossref
Selin Parmaksız & Sevda Şenel. 2021. Chitosan for Biomaterials IV. Chitosan for Biomaterials IV 293 379 .
Sevda Şenel & Selin Yüksel. (2020) Chitosan-based particulate systems for drug and vaccine delivery in the treatment and prevention of neglected tropical diseases. Drug Delivery and Translational Research 10:6, pages 1644-1674.
Crossref
Selin Yüksel, Mert Pekcan, Nuhan Puralı, Güneş Esendağlı, Ece Tavukçuoğlu, Vanessa Rivero-Arredondo, Luis Ontiveros-Padilla, Constantino López-Macías & Sevda Şenel. (2020) Development and in vitro evaluation of a new adjuvant system containing Salmonella Typhi porins and chitosan. International Journal of Pharmaceutics 578, pages 119129.
Crossref
Sevda Şenel. (2020) Current status and future of chitosan in drug and vaccine delivery. Reactive and Functional Polymers 147, pages 104452.
Crossref
Rui Zhao, Xiangyu Meng, Guiyan Jia, Yongzhong Yu & Bocui Song. (2019) Oral pre-administration of Purslane polysaccharides enhance immune responses to inactivated foot-and-mouth disease vaccine in mice. BMC Veterinary Research 15:1.
Crossref
Blessing Aderibigbe & Tobeka Naki. (2018) Design and Efficacy of Nanogels Formulations for Intranasal Administration. Molecules 23:6, pages 1241.
Crossref
Daniella Calderon-Nieva, Kalhari Bandara Goonewardene, Susantha Gomis & Marianna Foldvari. (2017) Veterinary vaccine nanotechnology: pulmonary and nasal delivery in livestock animals. Drug Delivery and Translational Research 7:4, pages 558-570.
Crossref
Chompoonuch Sawaengsak, Yasuko Mori, Koichi Yamanishi, Potjanee Srimanote, Wanpen Chaicumpa, Ampol Mitrevej & Nuttanan Sinchaipanid. (2014) Intranasal chitosan-DNA vaccines that protect across influenza virus subtypes. International Journal of Pharmaceutics 473:1-2, pages 113-125.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.